Browse the evidence

T2 cortisol concentrations were not associated with change in body composition over time.

Practitioners should note that changes in cortisol levels do not predict changes in body composition.

No significant differences by type of milk were observed for HDL-cholesterol, triacylglycerols, insulin, or glucose.

The type of milk consumed does not significantly impact other lipid or metabolic markers.

The oxidative stress markers, 4-HNE adducts and protein carbonyls, did not change at any time point.

Practitioners can conclude that immobilization does not significantly increase oxidative stress markers in muscle.

Insulin phosphorylates Akt and FoxO1, leading to reduced nuclear abundance of FoxO1 and repression of PGC-1alpha mRNA expression in healthy skeletal muscle.

Insulin's role in regulating PGC-1alpha expression is crucial for understanding metabolic responses in healthy muscle.

In insulin-resistant muscle, insulin fails to phosphorylate Akt or FoxO1, resulting in the inability to repress PGC-1alpha expression.

Understanding the failure of insulin action in insulin-resistant states can inform treatment strategies.

Insulin resistance is likely a polygenic disorder influenced by genetic predisposition.

Genetic factors should be considered in the assessment and management of insulin resistance.

There were no differences in fasting plasma leptin concentrations between insulin-sensitive and insulin-resistant subjects after adjusting for percent body fat.

Insulin resistance does not appear to influence leptin levels when body fat is controlled for.

Plasma leptin concentrations did not change in response to insulin in either the insulin-sensitive or insulin-resistant subjects.

Insulin does not appear to influence leptin levels acutely, which may have implications for metabolic regulation.

New imaging techniques may provide more accurate estimations of BAT mass in adults.

Improved imaging could enhance our understanding of BAT's role in metabolism.

The prediction models can differentiate solid foods from liquids with >91% accuracy.

This indicates that the method can accurately classify food types.

The metabolic effects of PIs may be associated with more effective viral suppression, as a greater proportion of patients in the PI group achieved undetectable levels of virus.

Further investigation is needed to understand the relationship between viral suppression and metabolic changes in patients on PI therapy.

Genetically based differences in circulating fatty acids may be due to differences in the conversion of fatty acid precursors.

Understanding genetic influences can help tailor dietary recommendations for fatty acid intake.

Males with Klinefelter syndrome (KS) have a shorter QTc interval compared to healthy controls.

Clinicians should be aware that males with KS may have altered cardiac function as indicated by QTc interval measurements.

Testosterone treatment further shortens the QTc interval in males with Klinefelter syndrome.

Testosterone therapy in males with KS may require monitoring of cardiac function due to its effects on QTc interval.

Untreated males with Klinefelter syndrome have a QTc interval comparable to healthy controls.

Untreated males with KS may not exhibit significant cardiac abnormalities compared to healthy individuals.

Human evidence for causality between the gut microbiome and body weight remains scarce.

Recognize the need for more research on the gut microbiome's role in obesity.

The decision tree yields an area under the receiver operating characteristic curve (AUC) of 0.967 for PCOS diagnosis.

Clinicians can use this decision tree to improve the accuracy of PCOS diagnosis.

Plasma adiponectin concentrations are not correlated with 24-hour respiratory quotient (RQ) in humans.

Adiponectin levels may not be a useful marker for assessing fat oxidation in healthy individuals.

Physiological concentrations of fasting plasma adiponectin do not play a role in the regulation of whole-body fat oxidation or energy expenditure in resting conditions.

Adiponectin may not be a target for increasing fat oxidation or energy expenditure in healthy individuals.

The variability in Z-band disruption within legs has a coefficient of variation (CV) of 41 +/- 30%.

Practitioners should be aware of the variability in muscle damage responses among individuals.

Naltrexone, bupropion, or their combination (B-N) is not associated with the incidence of major cardiovascular adverse events (MACE) compared with placebo.

Clinicians can consider that these treatments do not increase the risk of major cardiovascular events.

The current evidence does not demonstrate Blautia’s direct involvement as a pathogenic microbe in obesity development or progression.

Practitioners should consider that Blautia may not be a direct target for obesity treatment based on current evidence.

Further investigation into nutrient/training strategies is warranted to understand their effects on metabolic and cellular signaling pathways.

Researchers should prioritize studies on nutrient and training interactions to better understand their effects.

Statin-induced suppression of prenyl intermediates in the cholesterol biosynthetic pathway has been linked to stimulated atherosclerosis and heart failure.

Practitioners should be cautious about the long-term cardiovascular effects of statin use.